ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025
The Aftermath of the Battle Between Covid-19 & Invasive Fungal Sinusitis: A long Term Prospective Study.
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corona virus disease 2019 (COVID-19) pandemic saw a surge of invasive fungal sinusitis. This study prospectively followed up these cases to observe the long term sequelae and prognosis in these patients. A prospective, hospital based observational study was conducted at a tertiary referral center amongst 124 patients diagnosed with COVID- 19 associated invasive fungal sinusitis of the paranasal sinuses between April 2021 to September 2021. These patients were treated with surgery and or antifungals depending on the extend of the disease and surgical fitness of the patient and they were prospectively followed up till October 2023 by reviewing the clinical features, symptoms, serial nasal endoscopies and radiological imaging such as computed tomography and magnetic resonance imaging. The overall survival at the end of three months and eighteen months was 79.8% and 72.03% respectively. The most common presenting symptom in the outpatient department was facial pain in 67 patients (72.04%) which improved in only 17.91%. During the follow up period two patients developed progressive disease which required multiple surgeries.Covid-19 related invasive fungal sinusitis patients need judicious follow up for long term to minimise the possibility of progressive disease and associated complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.